Deferasirox increases BU blood concentrations

Bone Marrow Transplant. 2012 Feb;47(2):315-6. doi: 10.1038/bmt.2011.75. Epub 2011 Apr 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzoates / pharmacology*
  • Busulfan / blood
  • Busulfan / pharmacokinetics*
  • Deferasirox
  • Female
  • Humans
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics*
  • Iron Chelating Agents / pharmacology*
  • Middle Aged
  • Myelodysplastic Syndromes / therapy
  • Transplantation Conditioning / methods
  • Triazoles / pharmacology*

Substances

  • Benzoates
  • Immunosuppressive Agents
  • Iron Chelating Agents
  • Triazoles
  • Busulfan
  • Deferasirox